We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CLRB market cap is 59.43M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.71M | -8.29M | -9.41M | -12.55M | -12M |
| Net Income | -8.58M | -8.22M | -13.73M | -7.45M | -21.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.18M | -15.29M | -24.13M | -28.81M | -38.96M |
| Net Income | -14.09M | -15.09M | -24.12M | -28.6M | -37.98M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.84M | 6.51M | 21.55M | 12.08M | 42.91M |
| Total Liabilities | 7.5M | 6.98M | 16.98M | 13.43M | 16.74M |
| Total Equity | 7.33M | -467k | -13.35M | -1.36M | 26.17M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.25M | 58.66M | 37.2M | 21.59M | 12.08M |
| Total Liabilities | 3.19M | 3.86M | 4.16M | 6.08M | 13.43M |
| Total Equity | 9.06M | 54.8M | 33.05M | 15.51M | -1.36M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.18M | -14.71M | -22.78M | -32.38M | -13.36M |
| Investing | N/A | N/A | -597k | -864k | -22k |
| Financing | N/A | N/A | 22.5M | 22.94M | 43.85M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.69M | -13.93M | -22.57M | -25.22M | -32.38M |
| Investing | -25k | -62k | -141k | -226k | -864k |
| Financing | 9.02M | 60.55M | 1.25M | 9.61M | 22.94M |
| Market Cap | 59.43M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 40.57M |
| Average Volume (1 week) | 202.82k |
| Average Volume (1 Month) | 554.29k |
| 52 Week Change | -42.77% |
| 52 Week High | 4.45 |
| 52 Week Low | 1.385 |
| Spread (Intraday) | 0.01 (0.68%) |
| Company Name | Cellectar Biosciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cellectar.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
